Physics and Its Interfaces with Medicinal Chemistry and Drug Design

被引:2
|
作者
Santos, Ricardo N. [1 ]
Andricopulo, Adriano D. [1 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil
关键词
Medicinal chemistry; Physics; Drug design; Molecular interactions; ISOTHERMAL TITRATION CALORIMETRY; DOCKING; IMPROVE; BINDING; AGENTS; MICROTUBULES; METASTASIS; INHIBITORS; MECHANISM; DISCOVERY;
D O I
10.1007/s13538-013-0149-7
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Medicinal chemistry is a multidisciplinary subject that integrates knowledge from a variety of fields of science, including, but not limited to, chemistry, biology, and physics. The area of drug design involves the cooperative work of scientists with a diverse range of backgrounds and technical skills, trying to tackle complex problems using an integration of approaches and methods. One important contribution to this field comes from physics through studies that attempt to identify and quantify the molecular interactions between small molecules (drugs) and biological targets (receptors), such as the forces that govern the interactions, the thermodynamics of the drug-receptor interactions, and so on. In this context, the interfaces of physics, medicinal chemistry, and drug design are of vital importance for the development of drugs that not only have the right chemistry but also the right intermolecular properties to interact at the macromolecular level, providing useful information about the principles and molecular mechanisms underlying the therapeutic action of drugs. This article highlights some of the most important connections between physics and medicinal chemistry in the design of new drugs.
引用
收藏
页码:268 / 280
页数:13
相关论文
共 50 条
  • [31] Medicinal chemistry. II. Methodological principles of drug design
    Zefirova, ON
    Zefirov, NS
    VESTNIK MOSKOVSKOGO UNIVERSITETA SERIYA 2 KHIMIYA, 2000, 41 (02): : 103 - 108
  • [33] Metal complexes in medicinal chemistry: new vistas and challenges in drug design
    Thompson, KH
    Orvig, C
    DALTON TRANSACTIONS, 2006, (06) : 761 - 764
  • [34] Structure-Based Drug Design in Medicinal Chemistry: The Devil is in the Detail
    Kuhnert, Maren
    Diederich, Wibke E.
    SYNLETT, 2016, 27 (05) : 641 - 649
  • [35] From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design
    Turnaturi, Rita
    Piana, Silvia
    Spoto, Salvatore
    Costanzo, Giuliana
    Reina, Lorena
    Pasquinucci, Lorella
    Parenti, Carmela
    MOLECULES, 2023, 28 (20):
  • [36] RATIONAL DRUG DESIGN, MEDICINAL CHEMISTRY, PLANNED SERENDIPITY AND THE IMPACT OF AUTOMATION ON THE DRUG DISCOVERY PROCESS
    OCONNOR, S
    JOURNAL OF AUTOMATIC CHEMISTRY, 1993, 15 (01): : 9 - 12
  • [37] Physics and chemistry at organic transistor interfaces.
    Dodabalapur, A
    Schon, JH
    Crone, B
    Kloc, C
    Gelperin, A
    Katz, HE
    Bao, ZN
    Batlogg, B
    Lovinger, AJ
    Torsi, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U380 - U380
  • [38] BASIC STUDIES OF MOLECULAR DESIGN AND ITS NEW DEVELOPMENT OF MEDICINAL CHEMISTRY
    KANEMATSU, K
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1992, 112 (10): : 693 - 711
  • [39] THE ROLE OF MEDICINAL CHEMISTRY IN DRUG RESEARCH
    SOUDIJN, W
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1991, 13 (04) : 161 - 166
  • [40] Free Energy Methods in Drug Design: Prospects of "Alchemical Perturbation" in Medicinal Chemistry
    Williams-Noonan, Billy J.
    Yuriev, Elizabeth
    Chalmers, David K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 638 - 649